Nancy Connell

Nancy Connell


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KSKenneth Shatzkes
Kenneth Shatzkes
ESEric Singleton
Eric Singleton
CTChi Tang
Chi Tang
MZMichael Zuena
Michael Zuena
SSSean Shukla
Sean Shukla
NCNancy Connell
Nancy Connell
The proteobacteria Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus are obligate predators of Gram-negative bacteria, and have been proposed to be used to treat multidrug-resistant bacterial infections. The ability of predatory bacteria to reduce bacterial burden in vivo within the lungs of rats has been demonstrated, but it was unknown if predatory bacteria can attenuate systemic bacterial burden administered intravenously. In this study, we first assessed the safety of intravenous inoculation of predatory bacteria in rats. No rat morbidity or adverse histopathology of various organs due to predatory bacteria administration was observed. An increase in proinflammatory cytokines (TNFα and KC/GRO) was observed at two hours post-inoculation; however, cytokines returned to baseline levels by 18 hours. Furthermore, bacterial dissemination analysis demonstrated that predatory bacteria were efficiently cleared from the host by 20 days post-injection. To determine whether predatory bacteria could reduce bacterial burden in vivo, Klebsiella pneumoniae was injected into the tail veins of rats and followed with multiple doses of predatory bacteria over 16 or 24 hours. Predatory bacteria were unable to significantly reduce K. pneumoniae burden in the blood or prevent dissemination to other organs. The results suggest that predatory bacteria may not be effective for treatment of acute blood infections.

1 May 2020 in Vaccine
Verified
Journal Article
Closed access
DHDivya Hosangadi
Divya Hosangadi
KWKelsey Lane Warmbrod
Kelsey Lane Warmbrod
EMElena K. Martin
Elena K. Martin
AAAmesh Adalja
Amesh Adalja
ACAnita Cicero
Anita Cicero
NCNancy Connell
Nancy Connell

21 December 2018 in Microorganisms
Verified
Journal Article
Open access
PDF file
RRRiccardo Russo
Riccardo Russo
IKIrina Kolesnikova
Irina Kolesnikova
TKThomas Kim
Thomas Kim
SGShilpi Gupta
Shilpi Gupta
APAndroulla Pericleous
Androulla Pericleous
NCNancy Connell
Nancy Connell
Multi-drug resistant bacterial infections are a serious threat to global public health. Changes in treatment modalities and prudent use of antibiotics can assist in reducing the threat, but new approaches are also required for untreatable cases. The use of predatory bacteria, such as Bdellovibrio bacteriovorus, is among the novel approaches being considered as possible therapeutics for antibiotic resistant and/or unidentified bacterial infections. Previous studies have examined the feasibility of using predatory bacteria to reduce colony-forming units (CFUs) in the lungs of rats exposed to lethal doses of Klebsiella pneumoniae; here we apply the approach to the Tier 1 select agent Yersinia pestis, and show that three doses of B. bacteriovorus introduced every six hours reduces the number of CFUs of Y. pestis in the lungs of inoculated mice by 86% after 24 h of infection. These experiments further demonstrate that predatory bacteria may serve to combat Gram negative bacterial infections, including those considered potential bioweapon agents, in the future.

2 December 2015 in Microorganisms
Verified
Journal Article
Open access
PDF file
RRRiccardo Russo
Riccardo Russo
RCRichard Chae
Richard Chae
SMSomdatta Mukherjee
Somdatta Mukherjee
ESEric J. Singleton
Eric J. Singleton
JOJames L. Occi
James L. Occi
NCNancy Connell
Nancy Connell
Select Agents are microorganisms and toxins considered to be exploitable as biological weapons. Although infections by many Select Agents can be treated by conventional antibiotics, the risk of an emerging or engineered drug resistant strain is of great concern. One group of microorganisms that is showing potential to control drug resistant Gram-negative bacteria are the predatory bacteria from the genera Bdellovibrio spp. and Micavibrio spp. In this study, we have examined the ability of Bdellovibrio bacteriovorus (B. bacteriovorus) strain 109J, HD100 and Micavibrio aeruginosavorus (M. aeruginosavorus) ARL-13 to prey on a variety of Select Agents. Our findings demonstrate that B. bacteriovorus and M. aeruginosavorus are able to prey efficiently on Yersinia pestis and Burkholderia mallei. Modest predation was also measured in co-cultures of B. bacteriovorus and Francisella tularensis. However, neither of the predators showed predation when Burkholderia pseudomallei and Brucella melitensis were used as prey.

1 August 2017 in Health Security
Verified
Journal Article
Open access
NCNancy Connell
Nancy Connell

1 August 2021 in Health Security
Verified
Journal Article
Closed access
KWKelsey Lane Warmbrod
Kelsey Lane Warmbrod
JCJennifer Cole
Jennifer Cole
CSC. Matthew Sharkey
C. Matthew Sharkey
ASAparupa Sengupta
Aparupa Sengupta
NCNancy Connell
Nancy Connell
PDPatricia Delarosa
Patricia Delarosa